Wyeth files Prevnar-13 in US while GSK's rival vaccine gains EU approval
This article was originally published in Scrip
Executive Summary
Wyeth has filed a BLA with the US FDA for its 13-valent conjugated pneumococcal vaccine, Prevnar-13, for the prevention of pneumococcal diseases in infants and small children.